
Lisa L. Ouellette
@patentscholar
@StanfordLaw Prof & physics PhD. Researching IP & innovation. Coauthor of free patent casebook: patentcasebook.org
ID: 43448484
https://law.stanford.edu/directory/lisa-larrimore-ouellette/ 30-05-2009 00:57:57
22 Tweet
6,6K Takipçi
369 Takip Edilen



“Despite billions in public and private funding, therapeutic development in the United States remains poorly aligned with the country’s most pressing health needs,” says SLS's Lisa Ouellette, co-author of a new National Academies report on drug development reform. stanford.io/4o8AiZl

Report calls for developing drugs that are most needed. #IP expert Stanford Law School Prof. Lisa Larrimore Ouellette contributed to a report outlining strategies for reforming market-driven drug development. news.stanford.edu/stories/2025/0… Lisa L. Ouellette


Apply Now! Stanford IP Summer School, Aug. 18-22, in-person Stanford Law School, or join us live online from anywhere. Topics: US & Tech #IPLaw, #copyright #trademarks #patents #tradesecrets Design protection, #IP license, tech transfer. Learn more: conferences.law.stanford.edu/ipsummerschool… #techlaw


New article with Mark Lemley on how genAI facilitates academic plagiarism, why this shouldn't become a copyright/legal problem, and what universities should do about it (forthcoming in UChicago Law Review Online): papers.ssrn.com/abstract=53994…



Why doesn't Poll Everywhere have the very basic feature of being able to export activities for import into another instructor's account? Has anyone found a workaround for this problem? #EdTech



Looking forward to delivering the academic spotlight at the Stanford Law School Silicon Valley IP Forum on Oct. 3. Free registration here: conferences.law.stanford.edu/siliconvalleyi…

This meticulously careful and thoughtfully constructed paper by Azoulay-Matt Clancy-Li-Sampat is well worth reading. Thanks to the authors for so quickly pulling together such thoughtful evidence on such an important and policy-relevant question.

Thanks to David Zimmer for work on Jonathan Masur’s & my amicus brief in support of cert in MSN v. Novartis, drawing on our “Disclosure Puzzles in Patent Law” to explain why the Fed Cir’s approach to disclosure for after-arising technologies is incoherent supremecourt.gov/DocketPDF/25/2…

Lisa L. Ouellette Makes no sense. You can read the issued patent without registering, and the prosecution history is part of understanding the written patent (particularly the claims). I'm thinking this may be some sort of overreaction to the folks who've been doing fraudulent TM filings?